Top

11-09-2017 | Gastric cancer | Article

Validation of the 8th Edition of the AJCC TNM Staging System for Gastric Cancer using the National Cancer Database

Journal: Annals of Surgical Oncology

Authors: Haejin In, MD, MBA, MPH, I. Solsky, MD, B. Palis, MA, M. Langdon-Embry, MS, J. Ajani, MD, T. Sano, MD, PhD

Publisher: Springer International Publishing

Abstract

Background

The 8th edition AJCC gastric cancer staging manual was refined using Japanese and Korean data from the International Gastric Cancer Association (IGCA). This study evaluated the eighth edition’s validity for U.S. populations.

Methods

National Cancer Database (NCDB) was used to obtain data on gastric cancer patients diagnosed from 2004 to 2008 who underwent surgery and to examine differences in stage grouping and survival between AJCC 7th and 8th editions. Discrimination of models derived from NCDB and IGCA data was compared.

Results

Of 12,041 patients, median age was 65, 57.6% were male, median lymph nodes retrieved was 2 (0–76), 30.9% underwent distal/partial gastrectomy, and 49.8% received no adjuvant treatment. The 8th edition differed in that T1–T3 disease was upstaged with N3b, T4aN3a was downstaged from IIIC to IIIB, and T4bN0 and T4aN2 were downstaged from IIIB to IIIA. These changes resulted in increased patients in IIIA (1436 in the 7th edition to 2310 in the 8th) and IIIB (1737–1896) and decreased in IIIC (2100–1067). This also resulted in lower median survival for IIIA (28.7–25.0 months), IIIB (19.6–17.4), IIIC (13.7–11.8). The concordance index for the 8th edition applied to NCDB data was 0.719 [95% confidence interval (CI) 0.703–0.734), which is comparable to that for the 8th edition developed from IGCA data (0.775, 95% CI 0.770–0.780) and the 7th edition applied to NCDB data (0.720, 95% CI 0.704–0.735).

Conclusions

The 8th edition is valid for U.S. populations, showing clear separation of data with preservation of group order.

Union for International Cancer Control. TNM History, Evolution, and Milestones. http://www.uicc.org/sites/main/files/private/History_Evolution_Milestones_0.pdf. Accessed 22 Feb 2017.

American Joint Committee on Cancer. Desk References. https://cancerstaging.org/references-tools/deskreferences/pages/default.aspx, 2016.

Sano T, Coit DG, Kim HH, Roviello F, Kassab P, Wittekind C, et al. Proposal of a new stage grouping of gastric cancer for TNM classification: International Gastric Cancer Association staging project. Gastric Cancer. 2016; 20:217–225.CrossRefPubMed

American College of Surgeons. National Cancer Database. https://www.facs.org/quality%20programs/cancer/ncdb, 2016.

Bilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008;15(3):683–90.CrossRefPubMedPubMedCentral

American College of Surgeons. Facility Oncology Registry Data Standars (FORDS): Revised for 2016. https://www.facs.org/quality-programs/cancer/ncdb/registrymanuals/cocmanuals/fordsmanual. Accessed 5 Dec 2016.

System CSDC. Version 2.05. https://cancerstaging.org/cstage/schema/Pages/version0205.aspx, 2016.

Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): The TRIPOD Statement. Ann Intern Med. 2015;162:55–63. doi:10.7326/M14-0697.CrossRefPubMed

McGhan LJ, Pockaj BA, Gray RJ, Bagaria SP, Wasif N. Validation of the updated 7th edition AJCC TNM staging criteria for gastric adenocarcinoma. J Gastrointest Surg. 2012; 16(1):53–61; discussion 61.CrossRefPubMed

10.

Washington K. 7th edition of the AJCC cancer staging manual: stomach. Ann Surg Oncol. 2010;17(12):3077–9.CrossRefPubMed

11.

Ahn HS, Lee HJ, Hahn S, Kim WH, Lee KU, Sano T, et al. Evaluation of the seventh American joint committee on cancer/international union against cancer classification of gastric adenocarcinoma in comparison with the sixth classification. Cancer. 2010;116(24):5592–98.CrossRefPubMed

12.

Marano L, Boccardi V, Braccio B, Esposito G, Grassia M, Petrillo M, et al. Comparison of the 6th and 7th editions of the AJCC/UICC TNM staging system for gastric cancer focusing on the “N” parameter-related survival: the monoinstitutional NodUs Italian study. World J Surg Oncol. 2015;13:215.CrossRefPubMedPubMedCentral

13.

Bickenbach K, Strong VE. Comparisons of gastric cancer treatments: east vs. west. J Gastric Cancer. 2012;12(2):55–62.CrossRefPubMedPubMedCentral

14.

Palma DA. National Cancer Data Base: An important research tool, but not population-based. J Clin Oncol. 2017;35(5):571.CrossRef

15.

Deng J, Zhang R, Pan Y, Wang B, Wu L, Jiao X, et al. Comparison of the staging of regional lymph nodes using the sixth and seventh editions of the tumor-node-metastasis (TNM) classification system for the evaluation of overall survival in gastric cancer patients: findings of a case-control analysis involving a single institution in China. Surgery. 2014;156(1):64–74.CrossRefPubMed

16.

Reim D, Loos M, Vogl F, Novotny A, Schuster T, Langer R, et al. Prognostic implications of the seventh edition of the international union against cancer classification for patients with gastric cancer: the Western experience of patients treated in a single-center European institution. J Clin Oncol. 2013;31(2):263–71.CrossRefPubMed

17.

Datta J, Lewis RS Jr, Mamtani R, Stripp D, Kelz RR, Drebin JA, et al. Implications of inadequate lymph node staging in resectable gastric cancer: a contemporary analysis using the National Cancer Data Base. Cancer. 2014;120(18):2855–65.CrossRefPubMed

18.

Dubecz A, Solymosi N, Schweigert M, Stadlhuber RJ, Peters JH, Ofner D, et al. Time trends and disparities in lymphadenectomy for gastrointestinal cancer in the United States: a population-based analysis of 326,243 patients. J Gastrointest Surg. 2013;17(4):611–18.CrossRefPubMed

19.

Greenberg CC, Lipsitz SR, Neville B, In H, Hevelone N, Porter SA, et al. Receipt of appropriate surgical care for Medicare beneficiaries with cancer. Arch Surg. 2011;146(10):1128–34.CrossRefPubMedPubMedCentral

20.

Chen S, Zhao BW, Li YF, Feng XY, Sun XW, Li W, et al. The prognostic value of harvested lymph nodes and the metastatic lymph node ratio for gastric cancer patients: results of a study of 1,101 patients. PLoS ONE. 2012;7(11):e49424.CrossRefPubMedPubMedCentral

21.

Asoglu O, Karanlik H, Parlak M, Kecer M, Muslumanoglu M, Igci A, et al. Metastatic lymph node ratio is an independent prognostic factor in gastric cancer. Hepato-gastroenterology. 2009;56(91–92):908–13.PubMed

22.

Wong J, Rahman S, Saeed N, Lin HY, Almhanna K, Shridhar R, et al. Prognostic impact of lymph node retrieval and ratio in gastric cancer: a U.S. single center experience. J Gastrointest Surg. 2013;17(12):2059–66.CrossRefPubMed

23.

Lee JH, Kang JW, Nam BH, Cho GS, Hyung WJ, Kim MC, et al. Correlation between lymph node count and survival and a reappraisal of lymph node ratio as a predictor of survival in gastric cancer: a multi-instiutional cohort study. Eur J Surg Oncol. 2017;43(2):432–9.CrossRefPubMed

24.

Yamashita H, Deng J, Liang H, Seto Y. Re-evaluating the prognostic validity of the negative to positive lymph node ratio in node-positie gastric cancer patients. Surgery. 2017;161:1588–96.CrossRefPubMed

25.

Ajani JA, D’Amico TA, Almhanna K, Bentrem DJ, Chao J, Das P, et al. Gastric Cancer, Version 3.2016, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2016;14(10):1286–312.CrossRefPubMed

26.

Amin MB, Edge S, Greene F, Byrd DR, Brookland RK, Washington MK, et al. (editors) AJCC cancer staging manual. 8th ed. Cham: Springer International Publishing; 2017.

27.

Kattan MW, Hess KR, Amin MB, Lu Y, Moons KG, Gershenwald JE, et al. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016;66(5):370–74.CrossRefPubMedPubMedCentral